Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: Use of the mitogen-activated protein kinase kinase inhibitor PD098059

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1541-1550

  Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DAIDZEIN; ENZYME INHIBITOR; GENISTEIN; KETANSERIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL DIBUTYRATE; POTASSIUM CHLORIDE; PROTEIN TYROSINE KINASE INHIBITOR; SEROTONIN; SEROTONIN 2A RECEPTOR; TYRPHOSTIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; MESENTERIC ARTERY; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM CHANNELS; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0030434253     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. ADAM, L. P. AND HATHAWAY, D. R.: Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-caldesmon. 322: 56-60, 1993.
2. AKIYAMA, T., ISHIDA, J., NAKAGAWA, S., OGAWARD, H., WATANABE, S., ITOH, N., SHIBUYA, M. AND FUKAMI, Y.: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
3. AKIYAMA, T. AND OGAWAR, H.: Use and specificity of genistein as inhibitors of protein-tyrosine kinases. Methods in Enzymology, 201: 362-370, 1991.
4. 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268: 22235-22238, 1993.
5. ARUNLAKSHANA, O. AND SCHILD, H. O.: Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58, 1959.
6. BERK, B., ALEXANDER, R. W., BROCK, T. A., GIMBRONE, M. A. AND WEBB, R. C.: Vasoconstriction: A new activity for platelet-derived growth factor. Science 232: 87-89, 1986.
7. BERK, B., BROCK, T. A., WEBB, R. C., TAUBMAN, M. B., ATKINSON, W. J., GIMBRONE, M. A. AND ALEXANDER, R. W.: Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J. Clin. Invest. 75: 1083-1086, 1985.
8. 1-induced arterial contraction and phosphoinositide metabolism. Eur. J. Pharmacol. 132: 253-257, 1986.
9. BOHR, D. F. AND WEBB, R. C.: Vascular smooth muscle membrane in hypertension. Ann. Rev. Pharmacol. Toxicol. 28: 389-409, 1989.
10. BOLTON, T.: Mechanisms of action of transmitters and other substances on smooth muscles. Physiol. Rev. 59: 606-718, 1979.
11. BUTCHER, R. D., SCHOLLMANN, C. AND MARME, D.: Angiotensin II mediates intracellular signalling in vascular smooth muscle cells by activation of tyrosine specific protein kinases and c-raf-1. Biochem. Biophys. Res. Commun. 196: 1280-1287, 1993.
12. CANTLEY, L. C., AUGER, K. R., CARPENTER, C., DUCKWORTH, B., GRAZIANI, A., KAPELLER, R. AND SOLTOFF, S.: Oncogenes and signal transduction. Cell 64: 281-302, 1991.
13. CHANG, J. Y. AND OWMAN, C.: Involvement of specific receptors and calcium mechanisms in serotonergic contractile response of isolated cerebral and peripheral arteries from rats. J. Pharmacol. Exp. Ther. 242: 629-636, 1987.
14. 2 receptors mediating contraction in vascular smooth muscle. J. Pharmacol. Exp. Ther. 218: 421-425, 1981.
15. COURTNEIDGE, S.: Non-receptor protein-tyrosine kinases. In Protein Kinases, ed. by J. R. Woodgett, pp. 212-242, Oxford University Press, New York, 1994.
16. 2+ sensitivity for contraction of smooth muscle. Can. J. Physiol. Pharmacol. 72: 1434-1439, 1995.
17. DISALVO, J., STEUSLOFF, A., SEMENCHUK, L., SATOH, S., KOLQUIST, K. AND PFITZER, G.: Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190: 968-974, 1993.
18. DUDLEY, D. T., PANG, L., DECKER, S. J., BRIDGES, A. J. AND SALTIEL, A. R.: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 92: 7686-7689, 1995.
19. 2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators. Naunyn-Schmiedeberg Arch. Pharmacol. 335: 359-366, 1987.
20. FUJIO, Y., YAMADA, F., TAKAHASHT, K. AND SHIBATA, N.: Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin-A tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 195: 79-83, 1993.
21. GAZIT, A., YAISH, P., GILON, C. AND LEVITZKI, A.: Tyrphostin I: Synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32: 2344-2352, 1989.
22. GRANOT, Y., ERIKSON, E., GRIDMAN, H., VAN PUTTEN, V., WILLIAMS, B., SCHRIER, R. W. AND MALLER, J. L.: Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells. J. Biol. Chem. 268: 9564-9569, 1993.
23. 1Dβ" receptors. Eur. J. Pharmacol. 242: 75-82, 1993.
24. HERVE, P., DROUET, L., DOSQUET, C., LAUNAY, J., RAIN, B., SIMMONEAU, G., CAEN, J. AND DUROUX, P.: Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: Role of serotonin. Am. J. Med. 89: 117-120, 1990.
25. HOLLENBERG, M. D.: Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci. 15: 108-114, 1994.
26. HOYER, D., CLARKE, D. E., FOZARD, J. R., HARTIG, P. R., MARTIN, G. R., MYLECHARANE, E. J., SAXENA, P. R. AND HUMPHREY, P. P. A.: International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 158-203, 1994.
27. HUNTER, T. AND LINDBERG, A.: Receptor protein-tyrosine kinases. In Protein Kinases, ed. by James R. Woodgett, pp. 177-21, Oxford University Press, New York, 1994.
28. JIANG, M. J. AND MORGAN, K. G.: Intracellular calcium levels in phorbol esterinduced contractions of vascular muscle. Am. J. Physiol. 253: H1365-H1371, 1987.
29. 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase. Eur. J. Pharmacol. 277: 29-34, 1995.
30. KALSNER, S. AND RICHARDS, R.: Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: A mechanism for coronary spasm. Science. 223: 1435-1437, 1984.
31. KATOCH, S. S. AND MORELAND, R. S.: Agonist and membrane depolarization induced activation of MAP kinase in swine carotid artery. Am. J. Physiol. 269: H222-H229, 1995.
32. KAVANAUGH, W. M., TILLIAMS, L. T., IVES, H. E. AND COUGHLIN, S. R.: Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol. Endocrinol. 2: 599-605, 1988.
33. KAWASAKI, H. AND TAKASAKI, K.: Vasoconstrictor response induced by 5-hydroxy-tryptamine released from vascular adrenergic nerves by periarterial nerve stimulation. J. Pharmacol. Exp. Ther. 229: 816-822, 1984.
34. KAWASAKI, H., URABE, M. AND TAKASAKI, K.: Enhanced 5-hydroxytryptamine release from vascular adrenergic nerves in spontaneously hypertensive rats. Hypertension 10: 321-327, 1987.
35. KELLEHER, M. D., ABE, M. K., CHAO, T.-S. O., JAIN, M., GREEN, J. M., SOLWAY, J., ROSNER, M. R. AND HERSHENSON, M. B.: Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am. J. Physiol. 268: L894-L901, 1995.
36. KHALIL, R. A., MENICE, C. B., WANG, C.-L. A. AND MORGAN, K. G.: Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ. Res. 76: 1101-1108, 1995.
37. KOIDE, M., KAWAHARA, Y., TSUDA, T., ISHIDA, Y., SHII, K. AND YOKOYAMA, M.: Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J. Hypertension 10: 1173-1182, 1992.
38. KOLCH, W., HEIDECKER, G., KOCHS, G., HUMMEL, R., VAHIDL, H., MISCHAK, H., FINKENZELLER, G., MARME, D. AND RAPP, U. R.: Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 364: 249-252, 1993.
39. KRIBBEN, A., WIEDER, E. D., LI, X., VAN PUTTEN, V., GRANOT, Y., SCHRIER, R. W. AND NEMENOFF, R. A. : AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C. Am. J. Physiol. 265: C939-C945, 1993.
40. KYRIAKIS, J. M. AND AVRUCH, J.: S6 kinases and MAP kinases: sequential intermediates in insulin/mitogen-activated protein kinase cascades. In Protein Kinases, ed. by J. R. Woodgett, pp. 85-148, Oxford University Press, New York, 1994.
41. LAZAR, D. F., WIESE, R. J., BRADY, M. J., MASTICK, C. C., WATERS, S. B., YAMAUCHI, K., PESSIN, J. E., CUATRECASA, P. AND SALTIEL, A. R.: Mitogen activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol. Chem. 270: 20801-20807, 1995.
42. LEE, S.-L., WANG, W. W., LANZILLO, J. J. AND FANBURG, B. L.: Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells. Am. J. Physiol. 266: L53-L60, 1994.
43. MACLENNAN, S. J., BOLOFO, M. L. AND MARTIN, G. R.: Amplifying interactions between spasmogens in vascular smooth muscle. Biochem. Soc. Trans. 21: 1145-1150, 1993.
44. MARTIN, G. R.: Vascular receptors for 5-hydroxytryptamine: Distribution, function and classification. Pharmacol. Ther. 62: 283-324, 1994.
45. MCGREGOR, D. D. AND SMIRK, F. H.: Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats. Am. J. Physiol. 219: 687-690, 1970.
46. MERKEL, L. A., RIVERA, L. M., COLUSSI, D. J. AND PERRONE, M. H.: Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864. Biochem. Biophys. Res. Commun. 192: 1319-1326, 1993.
47. MIWA, Y., HIRATA, H.-I., MATSUDA, Y., SUEMATSU, M., KAWASHIMA, S. AND YOKOYAMA, M.: Augmented receptor-mediated calcium mobilization causes supersensitivity of contractile response to serotonin in atherosclerotic arteries. Circ. Res. 75: 1096-1102, 1994.
48. MOLLOY, C. J., TAYLOR, D. S. AND WEBER, H: Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268: 7338-7345, 1993.
49. MORGAN, K. G., DEFEO, T. T., WENC, K. AND WEINSTEIN, R.: Alterations of excitation-contraction coupling by platelet-derived growth factor in enzymatically isolated cultured vascular smooth muscle cells. Pfugers Arch. 405: 77-79, 1985.
50. 2+ channels and phopsholipase C. J. Pharmacol. Exp. Ther. 234: 442-446, 1985.
51. NEMECEK, G. M., COUGHLIN, S. R., HANDLEY, D. A. AND MOSKOWITZ, M. A.: Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. U.S.A. 83: 674-678, 1986.
52. 2+, verapamil, and ketanserin in rat tail artery and aorta. J. Cardiovasc. Pharmacol. 25: 603-610, 1995.
53. PANG, L., SAWADA, T., DECKER, S. J. AND SALTIEL, A. R.: Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585-13588, 1995.
54. RAPPORT, M. M., GREEN, A. A. AND PAGE, I. H.: Serum vasoconstrictor (serotonin). IV. Isolation and characterization. J. Biol. Chem. 176: 1243-1251, 1945.
55. SAURO, M. D. AND THOMAS, B.: Tyrophostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). J. Pharmacol. Exp. Ther. 267: 1119-1125, 1993.
56. SEMENCHUK, L. A. AND DISALVO, J.: Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS-Lett. 370: 127-130, 1995.
57. SOZERI, O., VOLLMER, K., LIYANGE, M., FRITH, D., KOUR, G., MARK III, G. E. AND STABEL, S.: Activation the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene 7: 2259-2262, 1992.
58. TAGAWA, H., TOMOIKE, H., MISUOKA, W., SATOH, S., KUGA, T., SHIMOKAWA, H., NAKAMURA, M. AND TAKESHITA, A.: Hyperreactivity of aortic smooth muscle to serotonin is altered to the presence of atheroma in Watanabe heritable hyperlipidaemic rabbits. Cardiovasc. Res. 27: 2164-2169, 1993.
59. TURLA, M. B. AND WEBB, R. C.: Vascular responsiveness to 5-hydroxytryptamine in experimental hypertension. In The Peripheral Actions of 5-Hydroxytryptamine, ed. by J. R. Fozard, pp. 327-353, Oxford University Press, Oxford, 1989.
60. VANHOUTTE, P., AMERY, A., BIRKENHAGER, W., BRECKENRIDGE, A., BUHLER, F., DISTLER, A., DORMANDY, J., DOYLE, A., FROHLICH, E., HANSSON, L., HEDNER, T., HOLLENBERG, N., JENSEN, H.-E., LUND-JOPHANSEN, P., MEYER, P., OPIE, L., ROBERTSON, I., SAFAR, M., SCHALEKAMP, M., SYMOENS, J., TRAP-JENSEN, J. AND ZANCHETTI, A.: Serotoninergic mechanisms in hypertension. Hypertension 11: 111-133, 1988.
61. VAN CORVEN, E. J., HORDIJK, P. L., MEDEMA, R. H., BOS, J. L. AND MOOLENAAR, W. H.: Pertussis toxin-sensitive activation of p21ras by G protein coupled receptor agonists in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 90: 1257-1261, 1993.
62. WATTS, S. W., YEUM, C. H., CAMPBELL, G. AND WEBB, R. C.: 5-HT stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J. Vasc. Res. 33: 288-298, 1996.
63. WATTS, S. W. AND WEBB, R. C.: Mechanism of ergonovine-induced contraction in the mesenteric artery from deoxycorticosterone acetate-salt hypertensive rats. J. Pharmacol. Exp. Ther. 269: 617-625, 1994.
64. WIJETUNGE, S., AALKJAER, C., SCHACHTER, M. AND HUGHES, A. D.: Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623, 1992.
65. 2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase. J. Biol. Chem. 268: 19196-19199, 1993.
66. YANG, S.-G., SAIFEDDINE, M. AND HOLLENBERG, M. D.: Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can. J. Physiol. Pharmacol. 70: 85-93, 1992.
67. YANG, S.-G., SAIFEDDINE, M., LANIYONU, A. AND HOLLENBERG, M. D.: Distinct signal transduction pathways for angiotensin II in guinea pig gastric smooth muscle: Differential blockade by indomethacin and tyrosine kinase inhibitors. J. Pharmacol. Exp. Ther. 264: 958-966, 1993.
68. YOSHIMASA, T., NAKAO, K., SUGA, S., KISHIMOTO, I., KISO, Y. AND IMURA, H.: Identification and endothelin-activation of multiple extracellular signal-regulated kinases in aortic smooth muscle cells. FEBS Lett. 311: 195-198, 1992.
69. ZHENG, C.-F. AND GUAN, K-L.: Cloning and characterization of two distinct human extracellular signal-regulated kinaae activator kinases, MEK1 and MEK2. J. Biol. Chem. 268: 11435-11439, 1993.
70. ZHENG, C.-F. AND GUAN, K.-L.: Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J. 13: 1123-1131, 1994.